MFS
EGRX

MSI Financial Services’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

MSI Financial Services’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$2K Sell
21
-54
-72% -$3.92K ﹤0.01% 3549
2016
Q3 		$5K Hold
75
– – ﹤0.01% 3163
2016
Q2 		$3K Hold
75
– – ﹤0.01% 3403
2016
Q1 		$3K Sell
75
-277
-79% -$17.6K ﹤0.01% 3438
2015
Q4 		$31K Buy
352
+267
+314% +$21.1K ﹤0.01% 2040
2015
Q3 		$6K Buy
+85
New +$7.07K ﹤0.01% 2343

Other funds holding EGRX

PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

MSI Financial Services's EGRX Position: Q4 2016 in Review

MSI Financial Services reduced its Eagle Pharmaceuticals, Inc. (EGRX) stake by 72% in Q4 2016, selling an estimated $3.92K and leaving 21 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #3549.

MSI Financial Services first reported a position in EGRX in Q3 2015 and has held it in 6 quarters since. The position peaked at $31K in Q4 2015. 149 funds tracked by Wall St. Rank hold EGRX as of Q4 2016.

  • MSI Financial Services held 21 shares of Eagle Pharmaceuticals, Inc. worth $2K as of Q4 2016.
  • MSI Financial Services sold 54 Eagle Pharmaceuticals, Inc. shares in Q4 2016, an estimated $3.92K.
  • Eagle Pharmaceuticals, Inc. made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #3549 holding.
  • MSI Financial Services first reported a position in Eagle Pharmaceuticals, Inc. in Q3 2015 and has held it in 6 quarters since.
  • MSI Financial Services's Eagle Pharmaceuticals, Inc. position peaked at $31K in Q4 2015.
  • 149 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.